688131 皓元医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额36,571317,749381,960(63,606)(240,233)
投资活动产生之现金流量净额252,843(202,043)(783,654)(328,511)(713,002)
筹资活动产生之现金流量净额105,577177,002791,479409,209360,324
汇率变动对现金及现金等价物的影响(17,324)(1,084)7,8453,11114,415
现金及现金等价物净增加/(减少)377,668291,624397,63020,202(578,496)
期初现金及现金等价物余额1,164,720873,096475,466455,2641,033,760
期末现金及现金等价物余额1,542,3881,164,720873,096475,466455,264